Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Prospects for the convergence of polyphenols with pharmaceutical drugs in type 2 diabetes: Challenges, risks, and strategies

Pharmacological Reviews(2024)10.1124/pharmrev.124.001074Source: DataRank Database

Prospects for the convergence of polyphenols with pharmaceutical drugs in type 2 diabetes: Challenges, risks, and strategies is a research paper published in Pharmacological Reviews (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.44)OA: greenTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Meenakshi Arora ORCID,Raghu Ganugula ORCID,Richard Friend ORCID,Rashmita Basu ORCID,M. N. V. Ravi Kumar ORCID

Live enrichment

PubMed:39952688 PMC:PMC13095421 OpenAlex:https://openalex.org/W4402858713

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: R01DK125372

National Eye Institute

Grant: R01EY028169

NIDDK NIH HHS

Grant: P30 DK079626

National Institutes of Health

FWCI

2.44

Citation Percentile

0.9%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC13095421/

publisherhttps://api.elsevier.com/content/article/PII:S0031699724000036?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0031699724000036?httpAccept=text/plain

publisherhttps://syndication.highwire.org/content/doi/10.1124/pharmrev.124.001074

Fields of Study

Natural Antidiabetic Agents StudiesDiet, Metabolism, and DiseaseEnzyme Catalysis and ImmobilizationHumansDiabetes Mellitus, Type 2PolyphenolsHypoglycemic AgentsAnimalsInsulinDrug Therapy, CombinationBlood Glucose

MeSH Terms

AnimalsHumansDiabetes Mellitus, Type 2InsulinBlood GlucoseHypoglycemic AgentsDrug Therapy, CombinationPolyphenols

Keywords

Type 2 diabetesPolyphenolDiabetes mellitusPharmacologyBusinessMedicineTraditional medicineChemistryRisk analysis (engineering)BiochemistryEndocrinologyAntioxidantPharmacokineticsOxidative stressInflammationDiabetesNanoparticlesDrug DeliveryDrug AbsorptionNutraceuticals